Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-02

Clinical Trial Update: Pirfenidone and Advanced Liver Fibrosis. [Phase 2]

View source ↗

Summary

Phase 2 trial update on pirfenidone for advanced liver fibrosis shows completion of the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

Sponsor: Grupo Mexicano para el Estudios de las Enfermedades Hepaticas | Conditions: Liver Fibrosis, Chronic Liver Disease | Phase 2 | Status: COMPLETED